STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

ZBH ZIMMER BIOMET HOLDINGS INCORPORATED StockScouter® Report

5

StockScouter® Score

ZIMMER BIOMET HOLDINGS INCORPORATED, a mid cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The ratio of ZBH’s forward price-to-earnings multiple to its estimated growth rate is below the average of comparably-sized companies in the StockScouter universe. Positive
  • Shares are under accumulation by financial institutions. Marginally positive for large companies like ZBH

 

Concerns

  • One or more analysts has modestly decreased quarterly earnings estimates for ZBH. Negative
  • Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 20% done.
Progress: 80% done.
Low
High

Core Model Grades

C
C
C
C

Previous Ratings

5
5
6